Company News

Sabinsa Earns Patent in Mexico

Expands its portfolio of intellectual property with Boswellin PS.

Sabinsa has expanded its portfolio of intellectual property with a new patent granted in Mexico for the company’s Boswellia serrata ingredient Boswellin PS.   This patent, MX328842, is for a synergistic composition containing boswellic acids and polysaccharides obtained from the Boswellia species for its property to downregulate pro-inflammatory markers. This includes, for example, PGE2, which drives the inflammatory process in different diseases.   “Inflammation is an underlying cause of many h...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters